- Report
- August 2025
- 191 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- July 2024
- 150 Pages
Global
From €3468EUR$3,750USD£2,895GBP
- Report
- July 2024
- 100 Pages
Global
From €3468EUR$3,750USD£2,895GBP
- Report
- July 2024
- 150 Pages
Global
From €3468EUR$3,750USD£2,895GBP
- Report
- July 2024
- 100 Pages
Global
From €3468EUR$3,750USD£2,895GBP
- Report
- November 2025
- 150 Pages
Global
From €3468EUR$3,750USD£2,895GBP
- Report
- March 2026
- 200 Pages
Saudi Arabia
From €2580EUR$2,789USD£2,153GBP
- Report
- July 2025
- 250 Pages
Africa, Middle East
From €3579EUR$3,869USD£2,986GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3579EUR$3,869USD£2,986GBP
- Report
- July 2025
- 350 Pages
Global
From €4577EUR$4,949USD£3,820GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3579EUR$3,869USD£2,986GBP
- Report
- July 2025
- 250 Pages
North America
From €3579EUR$3,869USD£2,986GBP
- Report
- July 2025
- 250 Pages
Europe
From €3579EUR$3,869USD£2,986GBP
- Report
- May 2023
- 140 Pages
Global
From €4577EUR$4,949USD£3,820GBP
- Report
- August 2025
- 223 Pages
Global
From €2312EUR$2,500USD£1,930GBP
- Report
- July 2024
- 166 Pages
Global
From €2312EUR$2,500USD£1,930GBP
- Report
- November 2024
- 159 Pages
Global
From €2312EUR$2,500USD£1,930GBP
- Report
- August 2022
- 96 Pages
Global
From €4620EUR$4,995USD£3,856GBP
- Report
- June 2026
- 118 Pages
Mexico
From €3699EUR$3,999USD£3,087GBP
- Report
- July 2024
- 115 Pages
Asia Pacific
From €4393EUR$4,750USD£3,666GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more